<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01833052</url>
  </required_header>
  <id_info>
    <org_study_id>HZL-01-TAVI</org_study_id>
    <nct_id>NCT01833052</nct_id>
  </id_info>
  <brief_title>CLaret Embolic Protection ANd TAVI - Trial</brief_title>
  <acronym>CLEAN-TAVI</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <brief_summary>
    <textblock>
      This prospective, randomized study was designed to investigate the benefit of using a
      Filter-Protection-Device (Claret MontageTM Dual Filter System) during transcatheter aortic
      valve implantation (TAVI) with a Medtronic CoreValve®.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate and Size of Cerebral Embolism</measure>
    <time_frame>2 days after Intervention</time_frame>
    <description>Primary endpoint ist the rate and the size of cerebral embolism in postinterventional Magnetic Resonance Imaging (MRI).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Frequency of Cerebral Perfusion Defects After TAVI</condition>
  <condition>Size of Cerebral Perfusion Defects After TAVI</condition>
  <arm_group>
    <arm_group_label>Cerebral Protection Filter</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient is treated with Cerebral protection Filter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Cerebral Protection Filter</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient is not treated with Cerebral protection Filter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAVI (Medtronic CoreValve)</intervention_name>
    <arm_group_label>Cerebral Protection Filter</arm_group_label>
    <arm_group_label>No Cerebral Protection Filter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Claret-Filter</intervention_name>
    <arm_group_label>Cerebral Protection Filter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be scheduled to undergo an endovascular aortic valve prosthesis
             (Medtronic CoreValve®) implant procedure with the femoral artery as the intended
             access site for the valve delivery system.

        Exclusion Criteria:

          -  Patient is unsuitable for TAVI

          -  Prior Stroke or TIA in the last 12 month

          -  Carotic stenosis &gt;70%

          -  Relevant stenosis of the brachiocephalic trunc or the right subclavian artery

          -  Expected Non-compliance for follow-ups

          -  Pregnancy

          -  Patient is already recruited for another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Leipzig Herzzentrum</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2013</study_first_submitted>
  <study_first_submitted_qc>April 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2013</study_first_posted>
  <last_update_submitted>May 2, 2015</last_update_submitted>
  <last_update_submitted_qc>May 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. A. Linke</investigator_full_name>
    <investigator_title>Prof. Dr. med. A. Linke</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

